Product Description
Galectin-7 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of -galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds -galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin-7 is a 15.4 kDa protein consisting of 136 amino acid residues
Biovision | 4647 | Galectin-7 human recombinant DataSheet
Biomolecule/Target: Galectin-7
Synonyms: Galactein 7, Galectin7, Gal-7, HKL-14, PI7, p53-induced gene 1 protein
Alternates names: Mammotropin, Luterotropic hormone, Lutetropin, Prlr, PRL, luteotropic hormone, LTH, PRLR, PRL-R, PRL R
Taglines: Modulates cellcell and cellmatrix interactions
NCBI Gene ID #: 24683
NCBI Gene Symbol: PRL
Gene Source: Human
Accession #: P01237
Recombinant: Yes
Source: E. coli
Purity by SDS-PAGEs: 95%
Assay: SDS-PAGE
Purity: 98%
Assay #2: HPLC
Endotoxin Level: <0.1 ng/g
Activity (Specifications/test method): N/A
Biological activity: The ED determined by the dose-dependent stimulation of the proliferation of rat lymphoma, Nb2-11 cells was found to be in the range of 0.1-1.0 ng/ml.
Results: 1-7 mg/ml.
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: 22.5 kDa
Concentration: N/A
Appearance: Lyophilized protein
Physical form description: Sterile filtered and lyophilized with no additives
Reconstitution Instructions: Reconstitute in HO to a concentration of 1.0 mg/ml. This solution can then be diluted into other aqueous buffers
Amino acid sequence: N/A